Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Preferred Stock IPO Market Is Frozen
This month's preferred stock IPO market is frozen, dominated by “Par Cross” and “Insider Buying” alerts, reflecting investor uncertainty due to trade tensions. The trade war and tariffs have created significant market volatility, causing companies to withdraw earnings guidance and defer investment decisions. Preferred stocks and baby bonds offer fixed payments, making them attractive during uncertain times, as they provide a “known return” amidst market unpredictability.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today
Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-time economic indicators show GDP growth of more than 2%, despite widespread recession fears, highlighting a disconnect between sentiment and fundamentals. Inflation truth vs. hype: Real-time data shows inflation is falling, contradicting consumer fears and demonstrating that stagflation panic may be premature.
Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)
Agilent Technologies, Inc. (NYSE:A ) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Padraig McDonnell - Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Daniel Brennan Alright, good. I guess we'll start in a minute or two early here, great day two of the TD Cowen Global Healthcare Conference.
Unlocking Agilent (A) International Revenues: Trends, Surprises, and Prospects
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q1 2025 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Padraig McDonnell - President and Chief Executive Officer Robert W. McMahon - Senior Vice President and Chief Financial Officer Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Rachel Vatnsdal - J.P.
Agilent (A) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended January 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.29 per share a year ago.
Agilent lowers annual revenue forecast on soft demand for medical equipment
Medical equipment maker Agilent lowered its annual revenue forecast on Wednesday, as it expects soft demand for its medical tools and equipment from smaller biotech companies.
Agilent to Report Q1 Earnings: What's in the Cards for the Stock?
A's fiscal first-quarter performance is likely to have been influenced by higher expenses, increased CapEx and the Lunar New Year timing shift.
